Resveratrol nanoparticle system improves dissolution properties and enhances the hepatoprotective effect of resveratrol through antioxidant and anti-inflammatory pathways

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 18, 2012, Pages 4662-4671

  Lee, Chiang Wen ^a   Yen, Feng Lin ^b   Huang, Haw Wei ^c   Wu, Tzu Hui ^d   Ko, Horng Huey ^b   Tzeng, Wen Sheng ^e   Lin, Chun Ching ^c,f  

^a CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b Department of Fragrance and Cosmetic Science ^*  (Taiwan)

^c Graduate Institute of Natural Products   (Taiwan)

^d Health Bureau of Kaohsiung County Government   (Taiwan)

^e CHI MEI FOUNDATION HOSPITAL   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

anti inflammatory; antioxidant; hepatoprotective; nanoparticles; resveratrol

Indexed keywords

ALANINE AMINOTRANSFERASE; AMORPHOUS TRANSFORMATION; ANIMAL MODEL; ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY ACTIVITY; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CASPASE-3; CHRONIC LIVER DISEASE; CLINICAL APPLICATION; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE; ENGINEERING PROCESS; HEPATOCYTES; HEPATOPROTECTION; HEPATOPROTECTIVE; HEPATOTOXICITY; HYDROGEN-BOND FORMATION; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATORY CYTOKINES; INTERLEUKIN-1; LIPID PEROXIDATION; NANOPARTICLE FORMULATION; NANOPARTICLE SYSTEMS; PHARMACOLOGICAL EFFECTS; PROTEIN EXPRESSIONS; REACTIVE OXYGEN SPECIES; RED WINE; RESVERATROL; TUMOR NECROSIS FACTORS;

ADSORPTION; AMINO ACIDS; DISSOLUTION; HYDROGEN; NITRIC OXIDE;

NANOPARTICLES;

ANTIOXIDANT; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; CHEMISTRY; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFECT; INTOXICATION; LIVER; MALE; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SOLUBILITY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CARBON TETRACHLORIDE POISONING; DRUG DELIVERY SYSTEMS; LIVER; MALE; NANOPARTICLES; RATS; RATS, WISTAR; SOLUBILITY; STILBENES;

ANIMALIA; RATTUS;

EID: 84861086062     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf2050137     Document Type: Conference Paper

References (45)

1. Jaeschke, H. Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts J. Gastroenterol. Hepatol. 2011, Suppl 1, 173-179
2. Ferre, N.; Claria, J. New insights into the regulation of liver inflammation and oxidative stress Mini Rev. Med. Chem. 2006, 6, 1321-1330 (Pubitemid 44890539)
3. Obrenovich, M. E.; Nair, N. G.; Beyaz, A.; Aliev, G.; Reddy, V. P. The role of polyphenolic antioxidants in health, disease, and aging Rejuvenation Res. 2010, 13, 631-643
4. Rodrigo, R.; Miranda, A.; Vergara, L. Modulation of endogenous antioxidant system by wine polyphenols in human disease Clin. Chim. Acta 2011, 12, 410-424
5. Lippi, G; Franchini, M; Favaloro, E. J.; Targher, G. Moderate red wine consumption and cardiovascular disease risk: Beyond the "French paradox" Semin. Thromb. Hemost. 2010, 36, 59-70
6. Standridge, J. B.; Zylstra, R. G.; Adams, S. M. Alcohol consumption: An overview of benefits and risks South. Med. J. 2004, 97, 664-672 (Pubitemid 38955844)
7. Bujanda, L. The effects of alcohol consumption upon the gastrointestinal tract Am. J. Gastroenterol. 2000, 95, 3374-3382
8. Lyons, M. M.; Yu, C.; Toma, R. B. Resveratrol in raw and baked blueberries and bilberries J. Agric. Food Chem. 2003, 51, 5867-5870
9. de la Lastra, C. A.; Villegas, I. Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications Biochem. Soc. Trans. 2007, 35, 1156-1160 (Pubitemid 350206449)
10. Zhang, F.; Liu, J.; Shi, J. S. Anti-inflammatory activities of resveratrol in the brain: Role of resveratrol in microglial activation Eur. J. Pharmacol. 2010, 636, 1-7
11. Shukla, Y.; Singh., R. Resveratrol and cellular mechanisms of cancer prevention Ann. N. Y. Acad. Sci. 2011, 1215, 1-8
12. Albani, D.; Polito, L.; Signorini, A.; Forloni, G. Neuroprotective properties of resveratrol in different neurodegenerative disorders Biofactors 2010, 36, 370-376
13. Das, M.; Das, D. K. Resveratrol and cardiovascular health Mol. Aspects Med. 2010, 31, 503-512
14. Bishayee, A.; Darvesh, A. S.; Politis, T.; McGory, R. Resveratrol and liver disease: From bench to bedside and community Liver Int. 2010, 30, 1103-1114
15. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: The in vivo evidence Natl. Rev. Drug Discovery 2006, 5, 493-506 (Pubitemid 44136961)
16. Ratnam, D. V.; Ankola, D. D.; Bhardwaj, V.; Sahana, D. K.; Kumar, M. N. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective J. Controlled Release 2006, 113, 189-207 (Pubitemid 43983041)
17. Mallick, S.; Pattnaik, S.; Swain, K.; De, P. K. Current perspectives of solubilization: Potential for improved bioavailability Drug Dev. Ind. Pharm. 2007, 33, 865-873 (Pubitemid 47345858)
18. Hu, J.; Johnston, K. P.; Williams, R. O., 3rd. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs Drug Dev. Ind. Pharm. 2004, 30, 233-245 (Pubitemid 38451748)
19. Bilati, U.; Allemann, E.; Doelker, E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles Eur. J. Pharm. Sci. 2005, 24, 67-75 (Pubitemid 40051288)
20. Wu, T. H.; Yen, F. L.; Lin, L. T.; Tsai, T. R.; Lin, C. C.; Cham, T. M. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles Int. J. Pharm. 2008, 346, 160-168
21. Ikeda, H.; Kume, Y.; Tejima, K.; Tomiya, T.; Nishikawa, T.; Watanabe, N.; Ohtomo, N.; Arai, M.; Arai, C.; Omata, M.; Fujiwara, K.; Yatomi, Y. Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293, 911-917
22. Llacuna, L.; Mari, M.; Lluis, J. M.; Garcia-Ruiz, C.; Fernandez-Checa, J. C.; Morales, A. Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion Am. J. Pathol. 2009, 174, 1776-1785
23. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 1979, 95, 351-358 (Pubitemid 9194347)
24. Jyothi, N. V.; Prasanna, P. M.; Sakarkar, S. N.; Prabha, K. S.; Ramaiah, P. S.; Srawan, G. Y. Microencapsulation techniques, factors influencing encapsulation efficiency J. Microencapsul. 2010, 27, 187-197
25. Tzeng, C. W.; Yen, F. L.; Wu, T. H.; Ko, H. H.; Lee, C. W.; Tzeng, W. S.; Lin, C. C. Enhancement of dissolution and antioxidant activity of kaempferol using a nanoparticle engineering process J. Agric. Food Chem. 2011, 59, 5073-5080
26. PiñoÌn-Segundo, E.; Ganem-Quintanar, A.; Alonso-Perez, V.; Quintanar-Guerrero, D. Preparation and characterization of triclosan nanoparticles for periodontal treatment Int. J. Pharm. 2005, 294, 217-232 (Pubitemid 40462337)
27. Horisawa, E.; Danjo, K.; Haruna, M. Physical properties of solid dispersion of a nonsteroidal anti-inflammatory drug (M-5011) with Eudragit E Drug Dev. Ind. Pharm. 2000, 26, 1271-1278 (Pubitemid 32037423)
28. Choi, J. H.; Kim, D. W.; Yun, N.; Choi, J. S.; Islam, M. N.; Kim, Y. S.; Lee, S. M. Protective effects of hyperoside against carbon tetrachloride-induced liver damage in mice J. Nat. Prod. 2011, 74, 1055-1060
29. Dokoumetzidis, A.; Macheras, P. A century of dissolution research: From Noyes and Whitney to the biopharmaceutics classification system Int. J. Pharm. 2006, 321, 1-11 (Pubitemid 44247428)
30. Xia, D.; Cui, F.; Piao, H.; Cun, D.; Piao, H.; Jiang, Y.; Ouyang, M.; Quan, P. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats Pharm. Res. 2010, 27, 1965-1976
31. Kamiya, S.; Kurita, T.; Miyagishima, A.; Itai, S.; Arakawa, M. Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying Eur. J. Pharm. Biopharm. 2010, 74, 461-466
32. Andrews, G. P.; AbuDiak, O. A.; Jones, D. S. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions J. Pharm. Sci. 2010, 99, 1322-1335
33. Li, B.; Wen, M.; Li, W.; He, M.; Yang, X.; Li, S. Preparation and characterization of baicalin-polyvinylpyrrolidone coprecipitate Int. J. Pharm. 2011, 408, 91-96
34. Weber, L. W.; Boll, M.; Stampfl, A. Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model Crit. Rev. Toxicol. 2003, 33, 105-136 (Pubitemid 36432872)
35. 4-intoxicated mice Toxicology 2011, 280, 33-43
36. Kamalakkannan, N.; Rukkumani, R.; Varma, P. S.; Viswanathan, P.; Rajasekharan, K. N.; Menon, V. P. Comparative effects of curcumin and an analogue of curcumin in carbon tetrachloride-induced hepatotoxicity in rats Basic Clin. Pharmacol. Toxicol. 2005, 97, 15-21 (Pubitemid 40896816)
37. Koop, D. R. Oxidative and reductive metabolism by cytochrome P450 2E1 FASEB J. 1992, 6, 724-730
38. Basu, S. Carbon tetrachloride-induced lipid peroxidation: Eicosanoid formation and their regulation by antioxidant nutrients Toxicology 2003, 189, 113-127 (Pubitemid 36725027)
39. Luster, M. I.; Simeonova, P. P.; Gallucci, R. M.; Bruccoleri, A.; Blazka, M. E.; Yucesoy, B. Role of inflammation in chemical-induced hepatotoxicity Toxicol. Lett. 2001, 120, 317-321 (Pubitemid 32375098)
40. Basu, S. Novel cyclooxygenase-catalyzed bioactive prostaglandin F2 alpha from physiology to new principles in inflammation Med. Res. Rev. 2007, 27, 435-468 (Pubitemid 46991953)
41. Cummings, B. S.; McHowat, J.; Schnellmann, R. G. Phospholipase A2s in cell injury and death J. Pharmacol. Exp. Ther. 2000, 294, 793-799 (Pubitemid 30666826)
42. Bhave, V. S.; Donthamsetty, S.; Latendresse, J. R.; Mehendale, H. M. Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A2-mediated progression of acute liver injury Toxicol. Appl. Pharmacol. 2008, 228, 239-246
43. Roerdink, F.; Regts, J.; Van Leeuwen, B.; Scherphof, G. Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats Biochim. Biophys. Acta 1984, 770, 195-202 (Pubitemid 14165260)
44. Drummond, D. C.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 1999, 51, 691-743
45. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-circulating and target-specific nanoparticles: Theory to practice Pharmacol. Rev. 2001, 53, 283-318 (Pubitemid 32476118)